Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19.
Mil Med Res
; 7(1): 19, 2020 04 20.
Artículo
en Inglés
| MEDLINE | ID: covidwho-72008
ABSTRACT
Since December 2019, a novel type of coronavirus disease (COVID-19) in Wuhan led to an outbreak throughout China and the rest of the world. To date, there have been more than 1,260,000 COVID-19 patients, with a mortality rate of approximately 5.44%. Studies have shown that coagulation dysfunction is a major cause of death in patients with severe COVID-19. Therefore, the People's Liberation Army Professional Committee of Critical Care Medicine and Chinese Society on Thrombosis and Hemostasis grouped experts from the frontline of the Wuhan epidemic to come together and develop an expert consensus on diagnosis and treatment of coagulation dysfunction associated with a severe COVID-19 infection. This consensus includes an overview of COVID-19-related coagulation dysfunction, tests for coagulation, anticoagulation therapy, replacement therapy, supportive therapy and prevention. The consensus produced 18 recommendations which are being used to guide clinical work.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Neumonía Viral
/
Trastornos de la Coagulación Sanguínea
/
Infecciones por Coronavirus
/
Betacoronavirus
Tipo de estudio:
Estudios diagnósticos
/
Estudio pronóstico
Tópicos:
Covid persistente
Límite:
Anciano
/
Humanos
/
Middle aged
País/Región como asunto:
Asia
Idioma:
Inglés
Revista:
Mil Med Res
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
S40779-020-00247-7
Similares
MEDLINE
...
LILACS
LIS